Skip to Main Content

Paper Details

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.
Curr Oncol
21
2021
IFS, NTRK, NTRK gene fusion, NTRK gene fusions, Neurotrophic tyrosine receptor kinase gene fusions, Patients, Pediatric, TRK, TRK Fusion, TRK Fusion Cancer, TRK fusion cancer, children, differentiated thyroid carcinoma, entrectinib, glioma, infantile fibrosarcoma, larotrectinib, non-, patients, rhabdomyosarcoma, soft tissue sarcoma, solid tumours, spindle cell, spindle cell tumours, tumour, tumours, tyrosine, tyrosine receptor kinase
Author NameAffiliation
Rebecca J DeyellBritish Columbia Children's Hospital and Research Institute
Nada Jabado
Nada Jabado
Poul H SorensenUniversity of British Columbia
Poul H Sorensen
Poul H SorensenUniversity of British Columbia
Poul H Sorensen
  • 1 - 7

Datasets

Release 1.2